Difference between revisions of "Part:BBa K511200"
| Line 3: | Line 3: | ||
This part encodes a protein that combines the CI434 DNA-binding domain with the VP16 viral transactivation domain. This synthetic transactivator is able to moderately activate expression from minCMV-CI434 promoter variants. | This part encodes a protein that combines the CI434 DNA-binding domain with the VP16 viral transactivation domain. This synthetic transactivator is able to moderately activate expression from minCMV-CI434 promoter variants. | ||
| + | |||
| + | https://static.igem.org/mediawiki/2011/5/50/CI434_Characterization.jpg | ||
For more information, consult the MIT iGEM 2011 wiki <html><a href="http://2011.igem.org/Team:MIT/Results">here.</a></html> | For more information, consult the MIT iGEM 2011 wiki <html><a href="http://2011.igem.org/Team:MIT/Results">here.</a></html> | ||
Revision as of 04:05, 29 September 2011
CI434-VP16 Transactivator MammoBlock
This part encodes a protein that combines the CI434 DNA-binding domain with the VP16 viral transactivation domain. This synthetic transactivator is able to moderately activate expression from minCMV-CI434 promoter variants.
For more information, consult the MIT iGEM 2011 wiki here.
Sequence and Features
Assembly Compatibility:
- 10COMPATIBLE WITH RFC[10]
- 12COMPATIBLE WITH RFC[12]
- 21COMPATIBLE WITH RFC[21]
- 23COMPATIBLE WITH RFC[23]
- 25COMPATIBLE WITH RFC[25]
- 1000COMPATIBLE WITH RFC[1000]